Oncobiologics, Inc. (NASDAQ:OTLK – Get Free Report) Director Ghiath Sukhtian bought 8,539,709 shares of the stock in a transaction on Thursday, May 28th. The stock was purchased at an average cost of $0.59 per share, with a total value of $5,038,428.31. Following the completion of the purchase, the director directly owned 22,092,068 shares in the [...]